In cases of cardiovascular disease, for instance, it can regulate the actions of peripheral blood mononuclear cells (PBMCs), responsible for reductions in Treg cells and accordingly reduce expression of TGF-β1, further promoting disease progression (65). Here, TGFB1 is linked to cardiovascular disorder.